Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings
暂无分享,去创建一个
[1] G Becker,et al. Iron accumulation in the substantia nigra in rats visualized by ultrasound. , 1999, Ultrasound in medicine & biology.
[2] G Becker,et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound , 1999, Neurology.
[3] S. Fahn,et al. Study of movement disorders and brain iron by MR. , 1987, AJR. American journal of roentgenology.
[4] E. Ciceri,et al. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. , 1994, Journal of neural transmission. Supplementum.
[5] T. Chase,et al. Pathogenetic studies of motor fluctuations in Parkinson's disease. , 1988, Journal of neural transmission. Supplementum.
[6] A. Seidler,et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease , 1996, Neurology.
[7] A. Crossman,et al. A hypothesis on the pathophysiological mechanisms that underlie levodopa‐ or dopamine agonist‐induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment , 1990, Movement disorders : official journal of the Movement Disorder Society.
[8] M. Skalej,et al. Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.
[9] P Riederer,et al. Iron in the Parkinsonian substantia nigra. , 1997, Movement disorders : official journal of the Movement Disorder Society.
[10] G Becker,et al. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography , 1995, Neurology.
[11] P. Boesiger,et al. T2 relaxation time in patients with Parkinson's disease , 1993, Neurology.
[12] H. Schipper,et al. A Cellular Stress Model for the Sequestration of Redox‐Active Glial Iron in the Aging and Degenerating Nervous System , 1995, Journal of neurochemistry.
[13] J. Degroot,et al. Magnetic resonance imaging of the midbrain in Parkinson's disease , 1986, Annals of neurology.
[14] P. Riederer,et al. Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.
[15] R. Ordidge,et al. Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease , 1995, Neurology.
[16] C. Marsden,et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.
[17] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[18] P D Griffiths,et al. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.
[19] C. Marsden,et al. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease , 1992, Annals of neurology.
[20] P Riederer,et al. The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease. , 1993, Advances in neurology.
[21] C. Marsden,et al. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia. , 1993, Advances in neurology.
[22] C. Olanow. Magnetic resonance imaging in parkinsonism. , 1992, Neurologic clinics.
[23] Rolf-Dieter Stieglitz,et al. Das Freiburger-Persönlichkeitsinventar (FPI) , 2002 .
[24] A. Horsman,et al. Unchanged basal ganglia N‐acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy , 1997, Movement disorders : official journal of the Movement Disorder Society.
[25] H. Möller,et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic parkinson's disease: a multicenter pilot study , 1995 .
[26] N. Reynolds,et al. Qualitative Assessment of Parkinson's Disease: Study of Reliability and Data Reduction with an Abbreviated Columbia Scale , 1985, Clinical neuropharmacology.
[27] Francesco Federico,et al. Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders , 1997 .